The plant cannabinoid Δ9-tetrahydrocannabivarin can decrease signs of inflammation pain in mice. Bolognini, Daniele, et al.
British Journal of Pharmacology. 2010 Jun, 160(3): 677-687.

Cannabinoids and the gut: New developments and emerging concepts. Izzo, Angelo A, et al.
Pharmacology & Therapeutics. 2010 126: 21-38 (abstract).

Cannabidiol attenuates the appetitive effects of Δ9-tetrahydrocannabinol in humans smoking their chosen cannabis. Morgan, Celia J A, et al.
Neuropsychopharmacology. 2010 Aug, 35(9): 1879-1885.

Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Bhattacharyya, Sagnik, et al.
Neuropsychopharmacology. 2010 Feb, 35(3): 764-774.

Review on clinical studies with cannabis and cannabinoids 2005-2009. Hazekamp, Arno, et al.
Cannabinoids. 2010, 5 (special issue): 1-21.

Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis. Wolf, Susanna A, et al.
Cell Communication and Signaling. 2010, 8: 12 (abstract).

Cannabinoids and the gut: new developments and emerging concepts. Izzo, Angelo A, et al.
Pharmacology & Therapeutics. 2010, 126: 21-28.

ENTER YOUR EMAIL AND GET

10% OFF

YOUR NEXT ORDER

Be the first to learn about our new product additions, events and special promotions.